FOLH1 and cancer: By conjugating these NPs with specific ligands, such as prostate-specific membrane antigen (PSMA), researchers have aimed to enhance the specificity and efficacy of cancer treatments.111,112 To understand the mechanism of MIONPs targeting PSMA, it is crucial to probe the interaction between these NPs and PSMA.